Federal Supply Schedule 36F79719D0203
Award Date
8/1/19
Last Date to Order
7/31/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Upsher-Smith Laboratories LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Vivus LLC, provides for the delivery of pharmaceutical and hematology-related products under the General Services Administration (GSA) Federal Supply Schedule 65-IB. The contract has a ceiling value of $5,316,660.00 and a period of performance through January 31, 2026. The contract aims to procure a wide range of pharmaceutical and hematology products to support the healthcare needs of VA facilities...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12, a civilian agency of the U.S. government, to Genericus, Inc. The contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. This is a multiple award contract with a ceiling value of $850,000.00 and a period of performance ending on December 14, 2029. As a Federal Supply Schedule contract, it allows for the procurement of the specified products and...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned, small disadvantaged business. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and enables the VA to procure a wide range of pharmaceutical and hematology-related products from the vendor. The $2,225,000 multiple-award contract has a period of performance through June 14, 2026. As a Federal Supply Schedule contract, it...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Civicascript LLC, a non-profit limited liability company. The contract, valued at a ceiling of $225,000.00, is for the delivery of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS to the VA and has a period of performance through August 14, 2029. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows ordering from...
This Federal Supply Schedule contract (FSS-61-IB) was awarded by the U.S. Department of Veterans Affairs (VA) to Trupharma LLC, a for-profit limited liability company, on February 15, 2018. The contract has a ceiling value of $2,000,000.00 and a period of performance ending on July 31, 2025. The contract covers the provision of pharmaceutical and hematology-related products to the VA, which operates as a civilian agency. It is a multiple award schedule, meaning other vendors may also be...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Apotex Corp., provides for the delivery of 65 I B, Drugs, Pharmaceuticals, & Hematology Related Products. The contract has a ceiling value of $23,375,390.00 and a period of performance running from September 15, 2024 through September 14, 2029. As a Federal Supply Schedule (FSS) contract, this is a multiple award vehicle that allows federal agencies to procure the specified pharmaceutical and related...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Agepha Pharma USA LLC, a foreign-owned, self-certified small disadvantaged business and woman-owned small business. The contract, under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, has a ceiling value of $25,000.00 and a period of performance through June 14, 2024. The purpose of this interim agreement is to provide the VA with access to a variety of pharmaceutical...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Sumitomo Pharma America, Inc., provides a wide range of pharmaceutical and hematology-related products under the GSA Schedule 65 IB. The $2.53 billion multiple-award contract has a period of performance from July 1, 2019 to January 31, 2026. As a non-set-aside contract, it is open to all qualified vendors. The contract aims to procure drugs, pharmaceuticals, and hematology-related products to...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, to Legacy Pharma USA, Inc. The multiple-award contract has a ceiling value of $25,000.00 and a period of performance through September 15, 2023. The contract provides for the interim delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. As a Federal Supply...